Camptosar, FOLFOX Chemo Combo Improves Advanced Colon Cancer Outcomes
First-line treatment of advanced colorectal cancer with FOLFOXIRI chemotherapy plus Avastin (bevacizumab) in a Phase 2 clinical trial showed improvements in patient response rate and progression-free survival, according to recently ... Read more